Zepbound, Lilly Clinical trials like SURMOUNT-1 initiated tirzepatide at 2.5 mg weekly and increased by 2.5 mg every 4 weeks to reach maintenance doses of 5, 10, or 15 mg. The New England Journal of Medicine Maintaining higher doses can sustain or further weight reductionSURMOUNT-4 showed additional ~5.5% loss when continued, versus weight regain with placebo. PMC Important Medical Information and Disclaimers Important Current Status Update : On March 19, 2025, the FDA ended enforcement discretion for compounded tirzepatide
Patients often report improved blood sugar, reduced medication needs, and more regular menstrual cycles
They review your lab results, health history, and progress to create a strategy that evolves with you
Clinical experience: Nasal glucagon (Baqsimi) is feasible for rescue indications, with bioavailability of approximately 30%40%, rapid onset suitable for hypoglycemia rescue, and needle-free administration important for caregivers treating unconscious patients ( Best fit: Very potent peptides requiring small doses, rescue medications where needle-free administration is valuable (hypoglycemia, opioid overdose), or CNS-targeted strategies where direct nose-to-brain access may offer advantages over systemic administration
